These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 10981644)

  • 1. Hydroxychloroquine has no significant effect on lipids and apolipoproteins in Chinese systemic lupus erythematosus patients with mild or inactive disease.
    Tam LS; Li EK; Lam CW; Tomlinson B
    Lupus; 2000; 9(6):413-6. PubMed ID: 10981644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hydroxychloroquine Inhibits the Differentiation of Th17 Cells in Systemic Lupus Erythematosus.
    Yang J; Yang X; Yang J; Li M
    J Rheumatol; 2018 Jun; 45(6):818-826. PubMed ID: 29545450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The lipid, lipoprotein, and apolipoprotein effects of hydroxychloroquine in patients with systemic lupus erythematosus.
    Hodis HN; Quismorio FP; Wickham E; Blankenhorn DH
    J Rheumatol; 1993 Apr; 20(4):661-5. PubMed ID: 8496861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longitudinal Evaluation of Lipoprotein Variables in Systemic Lupus Erythematosus Reveals Adverse Changes with Disease Activity and Prednisone and More Favorable Profiles with Hydroxychloroquine Therapy.
    Durcan L; Winegar DA; Connelly MA; Otvos JD; Magder LS; Petri M
    J Rheumatol; 2016 Apr; 43(4):745-50. PubMed ID: 26834214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hydroxychloroquine increased cholesterol transfer to high-density lipoprotein in systemic lupus erythematosus: A possible mechanism for the reversal of atherosclerosis in the disease.
    Lang MG; Vinagre CG; Bonfa E; Freitas FR; Pasoto SG; Brito TS; Seguro LP; Maranhão RC; Borba EF
    Lupus; 2022 May; 31(6):659-665. PubMed ID: 35332823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cumulative dose of hydroxychloroquine is associated with a decrease of resting heart rate in patients with systemic lupus erythematosus: a pilot study.
    Cairoli E; Danese N; Teliz M; Bruzzone MJ; Ferreira J; Rebella M; Cayota A
    Lupus; 2015 Oct; 24(11):1204-9. PubMed ID: 25852050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydroxychloroquine reduces low-density lipoprotein cholesterol levels in systemic lupus erythematosus: a longitudinal evaluation of the lipid-lowering effect.
    Cairoli E; Rebella M; Danese N; Garra V; Borba EF
    Lupus; 2012 Oct; 21(11):1178-82. PubMed ID: 22641182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A cross-sectional study of hydroxychloroquine concentrations and effects in people with systemic lupus erythematosus.
    Carmichael SJ; Day RO; Tett SE
    Intern Med J; 2013 May; 43(5):547-53. PubMed ID: 23425382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Long-term effects of hydroxychloroquine on metabolism of serum lipids and left ventricular structure and function in patients of systemic lupus erythematosus].
    Meng J; Lu Y; Dong X; Liu H
    Zhonghua Yi Xue Za Zhi; 2014 Apr; 94(13):965-8. PubMed ID: 24851679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cholesterol-lowering effect of hydroxychloroquine in patients with rheumatic disease: reversal of deleterious effects of steroids on lipids.
    Wallace DJ; Metzger AL; Stecher VJ; Turnbull BA; Kern PA
    Am J Med; 1990 Sep; 89(3):322-6. PubMed ID: 2393036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Pharmacological Mechanisms and Therapeutic Activities of Hydroxychloroquine in Rheumatic and Related Diseases.
    Hu C; Lu L; Wan JP; Wen C
    Curr Med Chem; 2017; 24(20):2241-2249. PubMed ID: 28302011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydroxychloroquine in systemic lupus erythematosus (SLE).
    Ponticelli C; Moroni G
    Expert Opin Drug Saf; 2017 Mar; 16(3):411-419. PubMed ID: 27927040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of hydroxychloroquine on the lipid profile of patients with Sjögren syndrome.
    Migkos MP; Markatseli TE; Iliou C; Voulgari PV; Drosos AA
    J Rheumatol; 2014 May; 41(5):902-8. PubMed ID: 24634203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydroxychloroquine and glycemia in women with rheumatoid arthritis and systemic lupus erythematosus.
    Penn SK; Kao AH; Schott LL; Elliott JR; Toledo FG; Kuller L; Manzi S; Wasko MC
    J Rheumatol; 2010 Jun; 37(6):1136-42. PubMed ID: 20436082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dietary treatment of hyperlipidemia in patients with systemic lupus erythematosus.
    Hearth-Holmes M; Baethge BA; Broadwell L; Wolf RE
    J Rheumatol; 1995 Mar; 22(3):450-4. PubMed ID: 7783060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Favorable effects of hydroxychloroquine on serum low density lipid in patients with systemic lupus erythematosus: A systematic review and meta-analysis.
    Babary H; Liu X; Ayatollahi Y; Chen XP; Doo L; Uppaluru LK; Kwak MK; Kulaga C; Modjinou D; Olech E; Yoo JW
    Int J Rheum Dis; 2018 Jan; 21(1):84-92. PubMed ID: 28884965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hydroxychloroquine Serum Concentrations and Flares of Systemic Lupus Erythematosus: A Longitudinal Cohort Analysis.
    Mok CC; Penn HJ; Chan KL; Tse SM; Langman LJ; Jannetto PJ
    Arthritis Care Res (Hoboken); 2016 Sep; 68(9):1295-302. PubMed ID: 26749299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The administration of low doses of rituximab followed by hydroxychloroquine, prednisone and low doses of mycophenolate mofetil is an effective therapy in Latin American patients with active systemic lupus erythematosus.
    Galarza-Maldonado C; Kourilovitch MR; Molineros JE; Cardiel MH; Zurita L; Soroka NF; Yagur VY; Doukh N; Cervera R
    Autoimmun Rev; 2010 Dec; 10(2):108-11. PubMed ID: 20804861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determinants of hydroxychloroquine blood concentration variations in systemic lupus erythematosus.
    Jallouli M; Galicier L; Zahr N; Aumaître O; Francès C; Le Guern V; Lioté F; Smail A; Limal N; Perard L; Desmurs-Clavel H; Le Thi Huong D; Asli B; Kahn JE; Pourrat J; Sailler L; Ackermann F; Papo T; Sacré K; Fain O; Stirnemann J; Cacoub P; Leroux G; Cohen-Bittan J; Sellam J; Mariette X; Blanchet B; Hulot JS; Amoura Z; Piette JC; Costedoat-Chalumeau N;
    Arthritis Rheumatol; 2015 May; 67(8):2176-84. PubMed ID: 25989906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical impact of hydroxychloroquine dose adjustment according to the American Academy of Ophthalmology guidelines in systemic lupus erythematosus.
    Vázquez-Otero I; Medina-Cintrón N; Arroyo-Ávila M; González-Sepúlveda L; Vilá LM
    Lupus Sci Med; 2020 May; 7(1):. PubMed ID: 32434863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.